Jeffrey W. Albers - Insider Trading & Ownership

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Summary
The estimated net worth of Jeffrey W. Albers is at least $13.4M dollars as of September 11, 2024. Jeffrey W. Albers is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $13.4M. Jeffrey W. Albers is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $24.4K.
All Insider Reports
All Insider Reports

Ownership of Jeffrey W. Albers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $13.4M -$9.29M -40.9% Sep 9, 2024
SYRE Spyre Therapeutics, Inc. Director $24.4K May 14, 2024
KYMR Kymera Therapeutics, Inc. Director $0 -$741K -100% Aug 26, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Director Jun 28, 2022

Insider Transactions Reported by Jeffrey W. Albers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.